Fifth diseasehttps://en.wikipedia.org/wiki/Fifth_disease
Fifth disease ke e 'ngoe ea lipontšo tse ngata tse ka bang teng tsa tšoaetso ka parvovirus B19. Fifth disease e atile haholo bana.

Fifth disease e qala ka febere ea boemo bo tlase, hlooho e opileng, lekhopho le matšoao a kang a serame, joalo ka nko e tsubellang kapa e koetsoeng. Matšoao ana a feta, ebe matsatsi a latelang lekhopho le hlaha. Hangata lekhopho le bofubelu bo khanyang le hlaha sefahlehong, haholo-holo marameng (ka hona lebitso “lefu la marama le shapuoa”). Ho phaella marameng a mafubelu, bana ba atisa ho ba le lekhopho le bofubelu le lefu le lecha ’meleng kaofela, moo matsoho, sethoto le maoto e le libaka tse tloaelehileng haholo.

Hangata lefu lena ha le boima, empa ho basali ba bakhachane, tšoaetso ka trimester ea pele e amanang le hydrops fetalis, e bakang ho senyeheloa ke mpa ka tšohanyetso.

Kalafo
Ha ho hlokahale phekolo e khethehileng hobane hangata e ntlafala ka nako.

☆ AI Dermatology — Free Service
Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
  • Ngoana wa dilemo tse 16 le ngwana o na le Fifth disease — marama a bobeli a fetola a ba a mafubelu, joaloka a shapuoa, ‘me makhopho a maculopapular a hlaha meleng.
  • Erythema marameng a bobeli.
  • Mele o ka boela ho tsamaea le lekhopho le hlahang.
  • Ena ke lekhopho le hlahang marakong a linaha tse peli le bakwang ke tšoaetso ea kokoana‑hloko ea B19.
References Fifth disease (parvovirus B19) 35951969 
NIH
Fifth disease, e tsejoang hape e le erythema infectiosum, ke tšoaetso ea kokoana‑hloko e bakang ke human parvovirus B19. E atile haholo bana, hangata e ama bana pakeng tsa lilemo tse 4 ho isa ho tse 14. Hangata matšoao a qala ka feberu e seng matla, hlooho e opang, 'metso le maikutlo a kang a ntaramane. Bana ba ka 'na ba ba le lekhopho le lefubelu sefahlehong se tšoanang le ‘slapped cheeks’, hammoho le lekhopho ‘meleng’, matsoho le maoto. Ho batho ba baholo, bohloko ba manonyeletso ke tletlebo e tloaelehileng e ka hlahang libeke ka mor'a tšoaetso ea pele. Ka ho hlakileng, hoo e ka bang karolo ea 20 ho isa ho 30% lekholong ea batho ba baholo ba tšoaelitsoeng ke parvovirus B19 ba ka 'na ba se be le matšoao leha e le afe.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
 Exposure to fifth disease in pregnancy 20008596 
NIH
Kotsi ea ho ba le parvovirus B19 ho tloha ho 'm'a ho ea ho lesea e ka ba 33%, 'me e ka ba 3% ea basali ba nang le tšoaetso ba le mathata maseeng a bona. Ha 'm'e a tšoaetsoa pele ho libeke tse 20 tsa bokhachane, menyetla ea mathata a kang mathata a mali le ho bokellana ha mokelikeli 'meleng oa lesea e eketseha. Ho qala ho laola lefu lena, re lokela ho hlahloba hore na mokuli o kile a pepesehela parvovirus ka ho lekola li‑antibodies tse itseng (IgM). Haeba tlhahlobo e sa bontše ho pepeseha ha nako e fetileng empa e bontša tšoaetso ea morao‑rao, mokuli o hloka ho behela leihlo haufi‑ufi nakong ea bokhachane, ho kenyelletsa le lisebelisoa tsa ultrasound tse tloaelehileng ho hlahloba mathata a itseng a bophelo bo botle ba lesea.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.